Changeflow GovPing Healthcare & Life Sciences Citizen Petition Filed by Premier Research Inte...
Routine Consultation Added Consultation

Citizen Petition Filed by Premier Research International LLC

Email

Summary

Premier Research International LLC has filed a citizen petition with the Food and Drug Administration (FDA) regarding regulatory matters. The petition is available for public review and comment.

Published by FDA on regulations.gov . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

Premier Research International LLC has submitted a citizen petition to the Food and Drug Administration (FDA), identified by docket number FDA-2026-P-3166-0001. The specific details of the petition are not available for viewing or download directly from the provided information, but it is categorized as a citizen petition.

Regulated entities, particularly those in the pharmaceutical and drug manufacturing sectors, should be aware that this petition has been filed. While this is a non-binding consultation, interested parties may wish to review the petition once available to understand the issues raised and potentially submit comments to the FDA.

What to do next

  1. Monitor regulations.gov for availability of the citizen petition document.
  2. Review the petition content once accessible.
  3. Consider submitting comments to the FDA if the petition's subject matter is relevant to your operations.

Archived snapshot

Mar 27, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Content

There are no documents available to view or download

Attachments 1

Citizen Petition from Premier Research International, LLC

More Information
- Author(s) CDER
Download

Get daily alerts for Regs.gov: Food and Drug Administration

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from FDA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
FDA
Instrument
Consultation
Legal weight
Non-binding
Stage
Consultation
Change scope
Minor
Document ID
FDA-2026-P-3166-0001
Docket
FDA-2026-P-3166-0001

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Citizen Petitions
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Compliance frameworks
FDA 21 CFR Part 11
Topics
Drug Development Regulatory Affairs

Get alerts for this source

We'll email you when Regs.gov: Food and Drug Administration publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!